期刊文献+

代谢综合征患者葡萄糖代谢率与血浆脂联素及瘦素水平变化的关系 被引量:9

Relationship of glucose metabolic rate and plasma levels of adiponectin and lepfin in patients with metabolic syndrome
原文传递
导出
摘要 目的 探讨代谢综合征(MS)患者葡萄糖代谢率与血浆脂联素、瘦素水平的关系.方法 筛选30例MS患者和20名健康者为对照组.所有受试者均行高胰岛素-正常血糖钳夹试验;检测血浆脂联素与瘦素浓度及空腹胰岛素(FTNS)、血糖、血脂等生化指标;测定血压、腰围、身高、体重等人体参数.结果 (1)高胰岛素-正常血糖钳夹试验稳态时(120~150 min),MS组的葡萄糖代谢率显著低于对照组[(8.33±1.59)与(4.13±1.34)mg·kg^-1·min^-1],差异有统计学意义(P<0.01).(2)MS组的血浆脂联素水平显著低于对照组[(5.15±2.54)mg/L比(10.28±5.50)mg/L,P<0.01],瘦素水平显著高于对照组[(189±90)μg/L比(127±73)μg/L,P<0.01].(3)在MS组,腰围、体质指数、甘油三酯、高密度脂蛋白胆固醇、FINS、脂联素、瘦素等与葡萄糖代谢率相关(均P<0.05).结论 提示MS患者的胰岛素抵抗可能与血浆脂联素降低及瘦素升高有关. Objective To investigate the relationship of glucose metabolic rate (GMR) and plasma levels of adiponectin and leptin in patients with metabolic syndrome (MS). Methods A total of 30 MS subjects aged 36 -60 years old were selected as MS group. And 20 normal adults were selected as control group. The GMR was evaluated by the technique of hyperinsulinemic euglycemia clamp. The plasma concentrations of adiponectin and leptin were detected by enzyme-linked immunosorbent assay (ELISA). Blood pressure, waist circumference (WC), body weight and body height were measured.Results ( 1 ) During the steady state ( last 30 min), the GMR was significantly lower in MS group than that in control Group [ (4. 13 ± 1.34) mg· kg^- 1 · min^ -1 vs ( 8.33 ± 1.59 ) mg · kg^- 1 · min^ -1, P 〈 0. 01 ].(2) The plasma level of adiponectin was significantly lower in MS group than that in control group [ (5. 15 ±2. 54) μg/ml vs ( 10. 28 ±5.50 ) μg/ml, P 〈0. 01 ]. The plasma level of leptin were significantly higher in MS group than that in control group [(189.37 ±90.48) nng/ml vs(126.55 ±72.70) ng/ml, P 〈0.01].(3) In MS group, glucose metabolic rate was associated with WC, BMI, TG, HDL-C FINS, leptin, and adiponectin, ( all P 〈 0. 05 ). Conclusion The technique of hyperinsulinemic euglycemic clamp shows that the BMR of MS patients significantly decreases. It may be associated with their lowered plasma levels of adiponectin and leptin.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第16期1088-1091,共4页 National Medical Journal of China
基金 广东省科技计划项目(2007B080702015) 广东省医学科研基金(A2007632) 佛山市科技攻关项目(200708018)
关键词 代谢综合征X 脂联素 瘦素 葡萄糖代谢率 Metabolic syndrome X Adiponectin Leptin Glucose metabolic rate
  • 相关文献

参考文献12

  • 1Potenza MV,Mechanick JI.The metabolic syndrome:definition,global impact,and pathophysiology.Nutr Clin Pract,2009,24:560-577. 被引量:1
  • 2Gnaci(n)ska M,Malgorzewicz S,Stojek M,et al.Role of adipokines in complications related to obesity:a review.Adv Med Sci,2009,54:150-157. 被引量:1
  • 3Karbowska A,Boraty(n)ska M,Klinger M.Resistin:a pathogenic factor or a biomarker of metabolic disorders and inflammation?Postepy Hig Med Dosw,2009,63:485-491. 被引量:1
  • 4宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:611
  • 5Defronzo RA,Tobin JD,Andres R.Glucose clamp technique:a method for quantifying insulin secretion and resistance.Am J Physilo,1979,237:E214-223. 被引量:1
  • 6贾伟平,陈蕾,项坤三,陆俊茜,包玉倩,薛凤仙,陆蔚.扩展高胰岛素-正葡萄糖钳夹技术的建立[J].中华内分泌代谢杂志,2001,17(5):268-271. 被引量:46
  • 7Kellerer M,Lammers R,Fritsche A,et al.Insulin inhibits leptin receptor signalling in HEK293 cells at thelevel of janus kinase-2:a potential mechanism for hyperinsulinaemia-associated leptin resistance.Diabetologia,2001,44:1125-1132. 被引量:1
  • 8Guran T,Turan S,Bereket A,et al.The role of leptin,soluble leptin receptor,resistin and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children.Eur J Pediatr,2009,168:1043-1048. 被引量:1
  • 9Gnaci(n)ska M,Malgorzewicz S,Lysiak-Szydlowska W,et al.The serum profile of adipokines in overweight patients with metabolic syndrome.Endokrynol Pol,2010,61:36-41. 被引量:1
  • 10Yilmaz M,Bukan N,Demirci H,et al.Serum resistin and adiponectin levels in women with polycystic ovary syndrome.Gynecol Endocrinol,2009,25:246-252. 被引量:1

二级参考文献23

  • 1Lee K U,Diabetologia,1988年,31卷,285页 被引量:1
  • 2Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18. 被引量:1
  • 3Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468. 被引量:1
  • 4Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s. 被引量:1
  • 5Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517. 被引量:1
  • 6Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559. 被引量:1
  • 7Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591. 被引量:1
  • 8Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186. 被引量:1
  • 9Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236. 被引量:1
  • 10Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350. 被引量:1

共引文献653

同被引文献146

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部